Middle East Regulatory Policy Brief

Covering GCC, Sanctions, Procurement, SFDA, Operational Workflows. Explore key regulatory developments across GCC sectors including SFDA enforcement actions, AI medical software approvals, capital market reforms, sanctions on Iran, and operational workflow enhancements at Jeddah Port.

Show Notes

This episode delivers an in-depth review of critical regulatory updates impacting the GCC region, focusing on the Saudi Food and Drug Authority's latest enforcement and authorization activities, GCC capital market developments, and sanctions-related procurement challenges.

Highlights include the SFDA's decisive action against misleading medical device advertising that led to facility closures and legal referrals, underscoring the authority's commitment to truthful promotion and public health protection. Additionally, the SFDA granted marketing authorization for two innovative AI-enabled medical software solutions—Dental IQ and SAARIA—after rigorous clinical validations, marking a significant advancement in local healthcare technology.

On the operational front, the SFDA's CEO conducted a strategic review of workflows and technological systems at Jeddah Islamic Port to bolster regulatory oversight for imports and exports, aiming to enhance efficiency and collaboration with port authorities.

Capital market regulatory updates include Saudi Arabia’s approval of a major capital reduction for a ceramics producer and authorization for a securities advisory firm, reflecting ongoing market reforms. The episode also covers GCC-wide efforts to harmonize bond listings and integrate AI tools for market supervision.

For more information, visit the Carver Agents website.

Articles mentioned:
  1. SFDA Detects Misleading Claims in Medical Device Advertisement and Takes Legal Action
  2. Operation Economic Outcast Strikes Iran’s Global Terrorist Proxy Network
  3. Treasury Grounds Iranian Airlines with Sweeping Sanctions Action
  4. FinCEN Issues Whistleblower Bulletin on Iran-Related Illicit Finance
  5. The Capital Markets Authority Participates in the 32nd Meeting of Heads of Capital Markets Authorities Committee in GCC Countries
  6. SFDA Grants Marketing Authorization for Two Saudi-Developed AI-Enabled Medical Software Products for Dental and Ophthalmic Diagnosis
  7. SFDA CEO Visits Jeddah Islamic Port to Review Operational Workflows
  8. Approval for Capital Reduction of Saudi Company for Ceramic Pipes Production
  9. Authorization for Wazan Al-Nomou Company to Provide Securities Advisory Services
  10. FinCEN Issues Alert to Counter Iranian Procurement Efforts for Its Commercial Aviation Industry

What is Middle East Regulatory Policy Brief?

Regulatory news, updates, and insights for countries in the Middle East presented by the Carver Agents team

Welcome to Carver's Middle East Regulatory Updates for September 13, 2026.

The Saudi Food and Drug Authority, or SFDA, has detected misleading claims in a medical device advertisement, resulting in the closure of the healthcare facility involved and referral for legal proceedings. The SFDA emphasized the importance of truthful advertising to protect public health and maintain regulatory integrity. Advertisers must ensure compliance with SFDA regulations, verify medical information through official channels before publication, and report suspected violations via the unified call center at 19999.

In Saudi Arabia, the SFDA has granted marketing authorization for two AI-enabled medical software products developed locally. The products, Dental IQ and SAARIA, are designed for dental and ophthalmic diagnosis. This authorization follows a comprehensive regulatory review, including clinical evidence validation and local clinical studies. The SFDA requires ongoing post-marketing clinical follow-up to monitor real-world performance.

The SFDA's Chief Executive Officer recently visited Jeddah Islamic Port to review operational workflows and technological systems supporting import and export activities. This visit aims to strengthen collaboration between the SFDA and port authorities to enhance regulatory oversight of food, drugs, medical devices, and cosmetics entering Saudi Arabia. The SFDA plans to improve operational monitoring, traffic management, and procedural efficiency at the port.

The Capital Markets Authority of Saudi Arabia participated in the 32nd meeting of the Heads of Capital Markets Authorities Committee for Gulf Cooperation Council countries on September 7, 2026. Discussions focused on initiatives including bond and sukuk listings, promotion of dual listings for companies and funds across Gulf markets, electronic linkage of depository and settlement companies, and the use of artificial intelligence and supervisory technology in market supervision. These efforts aim to support regulatory convergence, investor protection, and market efficiency across the GCC.

In Saudi Arabia, the Capital Markets Authority approved a capital reduction request by the Saudi Company for Ceramic Pipes Production. The company's capital will be reduced from 150 million Saudi Riyal to 45,428,750 Saudi Riyal, with the number of shares decreasing from 15 million to 4,542,875. This reduction is subject to approval by the extraordinary general assembly and compliance with regulatory requirements. A detailed report on the capital reduction method and its expected effects must be published before the assembly meeting.

Also in Saudi Arabia, Wazan Al-Nomou Company has been authorized to commence securities advisory services following approval by the Capital Markets Authority dated January 7, 2025. This licensing confirms the company's compliance with regulatory requirements and supports market integrity and investor protection.